Co-Immunoprecipitation (Co-IP): Principles and Applications

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to Co-Immunoprecipitation

Co-immunoprecipitation (Co-IP) is a widely used biochemical technique for studying protein-protein interactions in their native cellular context. The method relies on the specificity of an antibody to capture a target protein—termed the "bait"—along with any other proteins physically associated with it, collectively known as the "prey." By isolating the bait protein from a complex mixture of cellular proteins, Co-IP enables researchers to determine whether two or more proteins interact within a cell, to identify novel interaction partners, and to characterize the composition of protein complexes.

The fundamental advantage of Co-IP over many other interaction detection methods is that it is performed under conditions that preserve native protein conformations and post-translational modifications. Because the interaction occurs in the cellular environment before lysis, Co-IP captures protein complexes as they exist in living cells, providing physiologically relevant information that cannot be obtained from recombinant in vitro systems alone.

What is Co-IP?

Co-IP is a variant of immunoprecipitation (IP). In a standard IP, an antibody against a specific protein is used to isolate that single protein from a cell lysate. In Co-IP, the same principle is extended: when you immunoprecipitate the bait protein, you simultaneously co-precipitate any proteins that are bound to it. The recovered protein complex is then analyzed, typically by Western blotting or mass spectrometry, to identify the interacting partners.

The term "co-immunoprecipitation" specifically refers to the fact that the prey proteins are not directly recognized by the antibody; they are brought down indirectly through their association with the bait. This distinguishes Co-IP from simple immunoprecipitation, where only the antigen itself is the target.

Why Study Protein-Protein Interactions?

Protein-protein interactions (PPIs) govern nearly every cellular process, including signal transduction, transcriptional regulation, cell cycle control, apoptosis, and metabolic pathway organization. Understanding which proteins interact with each other, and under what conditions, is fundamental to deciphering cellular function. Aberrant PPIs are implicated in numerous diseases, including cancer (e.g., dysregulated interactions in the p53-MDM2 pathway), neurodegenerative disorders (e.g., protein aggregation in Huntington's disease), and infectious diseases (e.g., viral proteins hijacking host machinery).

Co-IP provides a direct, biochemical readout of these interactions. It answers the question: "Do protein A and protein B physically associate in a cell?" This information is essential for building interaction networks, validating hits from high-throughput screens, and understanding the molecular mechanisms of disease.

Principles of Co-IP: Antibody-Antigen Recognition

The entire Co-IP experiment hinges on the specificity of the antibody-antigen interaction. An antibody raised against a particular protein will recognize and bind to that protein with high affinity, typically with a dissociation constant (Kd) in the nanomolar to picomolar range. This binding is the foundation upon which the entire purification strategy is built.

Bait and Prey Proteins

The bait protein is the protein you choose to immunoprecipitate. It is the known entity in your experiment—the protein you are interested in studying. The bait is recognized directly by the antibody. The prey proteins are the unknown (or suspected) interaction partners that co-precipitate with the bait. Prey proteins are not recognized by the antibody; their presence in the final eluate is entirely dependent on their physical association with the bait.

For example, if you are studying the interaction between the tumor suppressor p53 and the E3 ubiquitin ligase MDM2, you might use an anti-p53 antibody to immunoprecipitate p53 (the bait). If MDM2 (the prey) is bound to p53 in the cell, it will be co-precipitated and can be detected by Western blotting with an anti-MDM2 antibody.

The Role of Antibodies

The choice of antibody is the single most critical factor in a Co-IP experiment. The antibody must:

1. Recognize the native protein: Many antibodies are raised against denatured proteins or peptides and work well for Western blotting but fail to recognize the folded, native protein in solution. For Co-IP, the antibody must bind to an epitope that is accessible on the surface of the native protein.

1. Have high specificity: The antibody should not cross-react with other cellular proteins. Cross-reactivity leads to non-specific pull-down of unwanted proteins.

1. Have high affinity: The antibody-antigen interaction must be strong enough to withstand the washing steps. Low-affinity antibodies will lose their antigen during washes, resulting in poor recovery.

1. Not interfere with the interaction: Ideally, the antibody should bind to a region of the bait that is not involved in the interaction with prey proteins. If the antibody binds at or near the interaction interface, it may sterically hinder the binding of prey proteins, leading to false-negative results.

Monoclonal antibodies offer high specificity but may recognize only a single epitope, which could be masked in the native complex. Polyclonal antibodies recognize multiple epitopes and are often more robust for Co-IP, but they carry a higher risk of cross-reactivity. Many researchers use antibodies that have been validated for immunoprecipitation, as indicated by the manufacturer.

The Co-IP Workflow: Step-by-Step

A typical Co-IP experiment follows a series of well-defined steps. Each step must be optimized for the specific proteins and cell types being studied. The entire procedure typically takes 4–6 hours from cell lysis to elution, excluding downstream analysis.

Cell Lysis and Protein Extraction

The first step is to lyse cells to release their contents into a soluble lysate. The choice of lysis buffer is critical because it must solubilize the proteins while preserving protein-protein interactions.

1. Harvest cells: Cells are typically grown to 70–80% confluency in a 10 cm dish (approximately 5–10 × 10⁶ cells) or a 75 cm² flask. For suspension cells, collect by centrifugation at 300 × g for 5 minutes at 4°C.

1. Wash cells: Remove culture media and wash cells twice with ice-cold phosphate-buffered saline (PBS) to remove serum proteins.

1. Add lysis buffer: Add 500 µL–1 mL of ice-cold lysis buffer per 10 cm dish. A typical lysis buffer contains:
2. 50 mM Tris-HCl, pH 7.4
3. 150 mM NaCl
4. 1% Nonidet P-40 (NP-40) or 0.5% Triton X-100
5. 1 mM EDTA
6. Protease inhibitor cocktail (e.g., 1 mM phenylmethylsulfonyl fluoride, 1 µg/mL leupeptin, 1 µg/mL pepstatin A)

1. Incubate on ice: Incubate cells on ice for 15–30 minutes to allow complete lysis. Gentle agitation or rocking can improve lysis efficiency.

1. Clarify the lysate: Centrifuge at 14,000–20,000 × g for 10–15 minutes at 4°C. The supernatant contains the soluble proteins; the pellet contains cell debris, nuclei, and insoluble material. Transfer the supernatant to a fresh tube. This clarified lysate is your input material.

Incubation with Antibody

The clarified lysate is then incubated with the antibody against the bait protein.

1. Pre-clear the lysate (optional but recommended): To reduce non-specific binding, incubate the lysate with protein A/G beads alone (without antibody) for 30–60 minutes at 4°C with rotation. This removes proteins that bind non-specifically to the beads. Centrifuge and collect the supernatant.

1. Add antibody: Add 1–5 µg of antibody per 500 µL–1 mL of lysate. The optimal amount depends on the antibody's affinity and the abundance of the bait protein. Too little antibody results in incomplete capture; too much can increase non-specific background.

1. Incubate: Incubate the lysate-antibody mixture for 2–4 hours at 4°C with gentle rotation. Overnight incubation is sometimes used for low-abundance proteins, but longer incubations increase the risk of protein degradation and non-specific binding.

Capture with Protein A/G Beads

The antibody-antigen complexes are then captured on beads that bind to the antibody's Fc region.

1. Prepare beads: Protein A or Protein G agarose beads are washed twice with lysis buffer to remove storage solution. Protein A binds to the Fc region of rabbit antibodies with high affinity; Protein G binds better to mouse antibodies. A 50% slurry of beads is typically used.

1. Add beads to the lysate-antibody mixture: Add 20–50 µL of washed bead slurry (i.e., 10–25 µL packed beads) to the mixture.

1. Incubate: Incubate for 1–2 hours at 4°C with gentle rotation. This allows the antibody-antigen complexes to bind to the beads.

Washing and Elution

The beads are washed to remove unbound and non-specifically bound proteins, and the bound complexes are then eluted.

1. Centrifuge: Centrifuge the beads at 500–1,000 × g for 1–2 minutes at 4°C. Carefully remove the supernatant (this is the "flow-through" and can be saved for analysis).

1. Wash the beads: Add 500 µL–1 mL of ice-cold lysis buffer (or wash buffer with slightly higher salt concentration, e.g., 300 mM NaCl) to the beads. Gently invert or rotate for 5 minutes at 4°C. Centrifuge and remove the supernatant. Repeat for a total of 3–5 washes. Increasing the number of washes or the salt concentration reduces non-specific binding but may also disrupt weak interactions.

1. Elute the proteins: Add 30–50 µL of 2× SDS-PAGE sample buffer (containing 100 mM Tris-HCl pH 6.8, 4% SDS, 20% glycerol, 200 mM dithiothreitol, 0.2% bromophenol blue) to the beads. Heat at 95–100°C for 5–10 minutes. This denatures the proteins and disrupts all non-covalent interactions, releasing the antibody, bait, and prey proteins from the beads.

1. Collect the eluate: Centrifuge and collect the supernatant. This is your Co-IP sample, ready for analysis by SDS-PAGE and Western blotting.

Key Reagents and Buffers in Co-IP

The success of a Co-IP experiment depends heavily on the reagents and buffers used. Each component serves a specific purpose, and understanding their roles is essential for troubleshooting.

Lysis Buffer Composition

The lysis buffer must achieve a balance between solubilizing proteins and preserving interactions. The key components are:

Choosing the Right Beads

Protein A and Protein G are bacterial proteins that bind to the Fc region of immunoglobulins. The choice between them depends on the antibody species and isotype:

• Protein A: Binds strongly to rabbit IgG, human IgG1/2/4, and guinea pig IgG. Binds weakly to mouse IgG1 and rat IgG.
• Protein G: Binds strongly to mouse IgG1, rat IgG, and human IgG3. Binds all mouse and rabbit IgG subclasses more uniformly.

Many commercial beads are conjugated with both Protein A and Protein G (Protein A/G beads) to ensure binding to a wide range of antibody species and isotypes. The beads are typically agarose or magnetic. Agarose beads require centrifugation for separation; magnetic beads can be separated with a magnet, which is gentler and faster.

Detergents and Their Effects

The choice of detergent in the lysis buffer is critical. Non-ionic detergents such as NP-40 and Triton X-100 are mild and preserve protein-protein interactions. They work by disrupting lipid-lipid and lipid-protein interactions without denaturing proteins.

Ionic detergents such as sodium dodecyl sulfate (SDS) are denaturing and should be avoided in Co-IP lysis buffers. SDS disrupts all non-covalent interactions and would destroy the protein complex you are trying to isolate.

Zwitterionic detergents such as CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate) are intermediate in strength and can be useful for solubilizing membrane proteins while preserving some interactions.

For membrane protein complexes, stronger detergents such as digitonin or dodecyl-β-D-maltoside are often required. These detergents preserve protein-lipid interactions better than NP-40 but are more expensive and require optimization.

Experimental Controls and Validation

No Co-IP experiment is interpretable without proper controls. The most common and critical control is the negative control using a non-specific antibody.

Negative Controls

The purpose of a negative control is to distinguish specific interactions from non-specific binding to the antibody or beads. The standard negative control uses:

1. Normal IgG: Use the same amount of normal IgG from the same species as the primary antibody (e.g., normal rabbit IgG if your anti-bait antibody is a rabbit polyclonal). Normal IgG has no specificity for your bait protein but will bind to Protein A/G beads and will non-specifically capture proteins.

1. Beads only: A sample containing lysate and beads but no antibody. This controls for proteins that bind directly to the beads.

1. Lysate from knockout cells: If available, use cells where the bait protein has been knocked out. Any proteins pulled down in this sample are non-specific.

The negative control should be processed identically to the experimental sample. When analyzing by Western blot, any bands in the prey detection that appear in both the experimental and negative control samples are non-specific and should be disregarded.

Positive Controls

A positive control confirms that your experimental system is working. This could be:

1. Known interaction partner: If you are studying a novel protein, include a known interaction partner as a positive control. For example, if you are studying a new transcription factor, you might include a known co-activator that you expect to interact with it.

1. Overexpression of tagged proteins: Transfect cells with a tagged version of the bait protein and a tagged version of a known interactor. If the Co-IP works, you should detect both proteins.

1. Input control: Always include a sample of the clarified lysate (input) on your Western blot. This confirms that your proteins of interest are present in the lysate and that your antibodies work for detection.

Confirming Interactions

The standard method for analyzing Co-IP samples is Western blotting. The eluate is separated by SDS-PAGE, transferred to a membrane, and probed with antibodies against the suspected prey proteins. The presence of a prey protein band in the Co-IP sample but not in the negative control confirms the interaction.

For unbiased identification of novel interaction partners, the Co-IP eluate can be analyzed by mass spectrometry. In this case, the proteins are digested into peptides, and the peptides are identified by their mass-to-charge ratios. This approach can identify dozens or even hundreds of potential interaction partners in a single experiment. However, mass spectrometry requires careful controls and bioinformatic analysis to distinguish true interactors from contaminants.

Common Pitfalls and Troubleshooting

Even experienced researchers encounter problems with Co-IP. The following are the most common issues and their solutions.

Non-Specific Binding

Problem: You see bands in your negative control that are as strong as in your experimental sample.

Solutions:

• Increase washing stringency: Increase the number of washes from 3 to 5, or increase the salt concentration in the wash buffer from 150 mM to 300–500 mM NaCl.
• Pre-clear the lysate: Incubate the lysate with beads alone before adding the antibody to remove proteins that bind non-specifically to the beads.
• Use a different detergent: Switch from NP-40 to a milder detergent like digitonin, or reduce the detergent concentration.
• Use a different antibody: Some antibodies have higher non-specific binding than others. Try a different clone or a monoclonal antibody.
• Add BSA or blocking agents: Add 0.1–1% bovine serum albumin (BSA) to the lysis buffer to block non-specific protein binding sites.

Weak or No Signal

Problem: You cannot detect your prey protein in the Co-IP eluate, even though you know the interaction should exist.

Solutions:

• Increase the amount of starting material: Use more cells or more lysate. Co-IP requires more protein than a standard Western blot because you are diluting the prey protein through the immunoprecipitation process.
• Increase antibody amount: Use more antibody (5–10 µg instead of 1–5 µg) to capture more bait protein.
• Extend incubation time: Incubate the lysate with antibody overnight instead of 2–4 hours.
• Check the bait protein: Verify that your bait protein is actually being immunoprecipitated. Probe the Western blot with the anti-bait antibody to confirm that the IP worked.
• Optimize lysis conditions: If the interaction is weak or transient, use a milder lysis buffer (lower salt, milder detergent) or add chemical cross-linkers such as dithiobis(succinimidyl propionate) (DSP) to stabilize the interaction before lysis.
• Use a different antibody: Some antibodies disrupt protein-protein interactions. Try an antibody that recognizes a different epitope.

Protein Degradation

Problem: You see smearing or lower molecular weight bands on your Western blot, indicating protein degradation.

Solutions:

• Use fresh protease inhibitors: Protease inhibitor cocktails degrade over time. Prepare fresh lysis buffer with fresh inhibitors for each experiment.
• Work quickly and keep everything cold: Perform all steps on ice or at 4°C. Minimize the time between lysis and elution.
• Add additional protease inhibitors: Include a broader-spectrum cocktail containing inhibitors for serine, cysteine, and aspartic proteases, as well as aminopeptidases.
• Add phosphatase inhibitors: If you are studying phosphoproteins, include phosphatase inhibitors (e.g., 1 mM sodium orthovanadate, 10 mM sodium fluoride) to prevent dephosphorylation.

Antibody Quality

Problem: The antibody does not immunoprecipitate the bait protein efficiently, or it recognizes multiple non-specific bands.

Solutions:

• Use IP-validated antibodies: Many commercial antibodies are validated for immunoprecipitation. Check the manufacturer's data sheet.
• Test multiple antibodies: Different antibodies against the same protein can have dramatically different IP efficiencies.
• Consider using a tagged protein: If antibodies against your protein of interest are poor, you can express a tagged version (e.g., FLAG, HA, Myc) and use an anti-tag antibody for IP. This is a common strategy, though it requires transfection and may not reflect endogenous protein behavior.

Applications of Co-IP in Research

Co-IP is one of the most versatile tools in molecular biology, with applications ranging from validating single interactions to mapping entire interaction networks.

Confirming Known Interactions

The most common use of Co-IP is to confirm that two proteins interact in a cellular context. This is often done to validate interactions predicted by other methods, such as yeast two-hybrid screens or computational predictions. For example, if a yeast two-hybrid screen identified a novel interaction between a kinase and a transcription factor, Co-IP can confirm that this interaction occurs in mammalian cells.

Co-IP is also used to confirm interactions in a specific cell type or under specific conditions. For instance, you might show that two proteins interact only after stimulation with a growth factor, or only in certain cell lines. This provides important context for understanding the biological relevance of the interaction.

Discovering Novel Interactions

When combined with mass spectrometry, Co-IP becomes a powerful discovery tool. By immunoprecipitating a bait protein and identifying all co-precipitated proteins by mass spectrometry, you can identify novel interaction partners. This approach has been used to map large-scale protein interaction networks in yeast, Drosophila, and human cells.

For example, immunoprecipitation of the transcription factor p53 followed by mass spectrometry has identified dozens of novel interaction partners, including chromatin remodeling factors, RNA-binding proteins, and metabolic enzymes. These discoveries have expanded our understanding of p53's diverse cellular functions beyond its canonical role in apoptosis and cell cycle arrest.

Studying Complex Dynamics

Co-IP can be used to study how protein complexes change in response to cellular stimuli. By performing Co-IP at different time points after a stimulus, you can track the assembly and disassembly of protein complexes. For example, you might show that a signaling complex forms within 5 minutes of growth factor stimulation and dissociates after 30 minutes.

Co-IP can also be used to study the effects of mutations on protein interactions. By expressing wild-type and mutant versions of a protein and comparing their Co-IP profiles, you can identify which domains or amino acid residues are required for specific interactions.

Comparing Co-IP with Other Interaction Methods

Co-IP is one of several methods for studying protein-protein interactions. Each method has its strengths and limitations, and the choice of method depends on the specific question being asked.

Co-IP vs. Pull-Down

A pull-down assay is similar to Co-IP but uses a tagged protein (e.g., GST, His, or FLAG) as the bait instead of an antibody. The tagged protein is expressed in bacteria or eukaryotic cells, purified, and then incubated with a cell lysate. The interacting proteins are captured on beads that bind to the tag.

The key difference is that pull-down assays typically use recombinant proteins and are performed in vitro, whereas Co-IP uses endogenous proteins in their native cellular context. Pull-down assays are useful for studying direct interactions between purified proteins and for mapping interaction domains. However, they can produce false positives because the recombinant protein may not be properly folded or post-translationally modified. Co-IP is more physiologically relevant but requires a good antibody against the bait protein. For more details on tag-based purification, see His Tag Protein Purification.

Co-IP vs. Yeast Two-Hybrid

The Yeast Two Hybrid System is a genetic method for detecting protein-protein interactions in living yeast cells. A bait protein is fused to a DNA-binding domain, and a prey protein is fused to a transcriptional activation domain. If the two proteins interact, the activation domain is brought into proximity with the DNA-binding domain, activating a reporter gene.

Yeast two-hybrid is highly sensitive and can detect weak and transient interactions. It is also scalable for high-throughput screening. However, it has several limitations: the interaction occurs in yeast, not in the native cellular context of the proteins; the fusion proteins may fold incorrectly; and membrane proteins are difficult to study. Co-IP is generally considered more physiologically relevant because it is performed in the native cellular environment. See also the Yeast Two Hybrid Assay for more details.

Co-IP vs. FRET

Förster resonance energy transfer (FRET) is a biophysical method that measures the distance between two fluorescently labeled proteins. If two proteins are within 1–10 nm of each other, energy can be transferred from a donor fluorophore to an acceptor fluorophore, producing a measurable signal.

FRET has the advantage of being able to detect interactions in living cells in real time, providing spatial and temporal information. It can also detect weak and transient interactions. However, FRET requires the proteins to be tagged with fluorescent proteins, which can affect protein function. FRET also requires specialized equipment and careful controls. Co-IP provides a more direct biochemical readout but only gives a snapshot of the interaction at a single time point.

Practical Summary and Key Takeaways

Co-IP is a powerful and versatile technique for studying protein-protein interactions. Its success depends on careful experimental design, appropriate controls, and troubleshooting when problems arise.

Checklist for Co-IP

1. Choose a validated antibody against your bait protein that recognizes the native protein.
2. Prepare fresh lysis buffer with protease and phosphatase inhibitors.
3. Lyse cells on ice and clarify the lysate by centrifugation.
4. Pre-clear the lysate with beads alone to reduce non-specific binding.
5. Incubate lysate with antibody for 2–4 hours at 4°C with rotation.
6. Add Protein A/G beads and incubate for 1–2 hours at 4°C.
7. Wash beads 3–5 times with lysis buffer (or higher-salt wash buffer).
8. Elute with SDS-PAGE sample buffer and heat at 95–100°C for 5 minutes.
9. Analyze by Western blot with antibodies against the bait and suspected prey proteins.
10. Include proper controls: normal IgG negative control, input lysate, and positive control if available.

Final Advice for Students

When you are learning Co-IP, remember that the technique is conceptually simple but practically demanding. The most common reasons for failure are poor antibody quality, insufficient starting material, and inadequate controls. Always include a negative control—your results are meaningless without it. And when you see a band in your Co-IP sample, ask yourself: "Is this specific, or would it appear with any antibody?" The answer to that question is the difference between a real interaction and an artifact.

Frequently Asked Questions

What is co-immunoprecipitation (Co-IP)?

Co-immunoprecipitation (Co-IP) is a biochemical technique used to study protein-protein interactions. It involves using an antibody to immunoprecipitate a specific "bait" protein from a cell lysate, along with any "prey" proteins that are physically associated with it. The co-precipitated proteins are then identified and analyzed, typically by Western blotting or mass spectrometry.

How does co-immunoprecipitation work?

Co-IP works by exploiting the specificity of antibody-antigen recognition. An antibody against the bait protein is added to a cell lysate, where it binds to the bait. The antibody-bait complex, along with any prey proteins bound to the bait, is then captured on Protein A or Protein G beads. After washing to remove non-specifically bound proteins, the complex is eluted and analyzed. The presence of a prey protein in the eluate indicates that it interacts with the bait protein in the cell.

What is the purpose of a negative control in Co-IP?

A negative control in Co-IP distinguishes specific interactions from non-specific binding. The most common negative control uses normal IgG from the same species as the primary antibody. This control is processed identically to the experimental sample but lacks the specific antibody. Any proteins detected in the negative control are considered non-specific and should be disregarded when interpreting the experimental results.

Why is my Co-IP showing non-specific bands?

Non-specific bands in Co-IP are typically caused by proteins binding directly to the beads or to the antibody in a non-specific manner. To reduce non-specific binding, you can increase the number of washes, increase the salt concentration in the wash buffer, pre-clear the lysate with beads alone, or use a milder detergent. Using a different antibody or adding blocking agents like BSA can also help.

What is the difference between Co-IP and pull-down assays?

Co-IP uses an antibody to capture an endogenous bait protein from a cell lysate, preserving the native cellular context. Pull-down assays use a recombinant tagged protein (e.g., GST, His, FLAG) as the bait, which is purified and incubated with a lysate in vitro. Co-IP is more physiologically relevant, while pull-down assays are useful for studying direct interactions and mapping interaction domains. For more on tag-based methods, see His Tag Protein Purification.

Can Co-IP detect weak or transient interactions?

Co-IP can detect weak or transient interactions, but it requires optimization. To capture weak interactions, you may need to use a milder lysis buffer, add chemical cross-linkers to stabilize the interaction before lysis, or increase the amount of starting material. However, very weak or transient interactions may be lost during the washing steps, and alternative methods like FRET or the Yeast Two Hybrid System may be more suitable.

What are common mistakes in Co-IP experiments?

Common mistakes in Co-IP include: using an antibody that does not recognize the native protein, insufficient starting material, inadequate washing leading to high background, omitting negative controls, protein degradation due to insufficient protease inhibitors, and using denaturing detergents in the lysis buffer. Careful attention to experimental design and troubleshooting can help avoid these issues.

Key Takeaways

• Co-IP is a method for studying protein-protein interactions by using an antibody to pull down a bait protein and its associated prey proteins from a cell lysate.
• The success of Co-IP depends on the quality and specificity of the antibody, the choice of lysis buffer, and the stringency of the washing steps.
• Non-ionic detergents (NP-40, Triton X-100) preserve protein interactions, while ionic detergents (SDS) disrupt them and should be avoided in lysis buffers.
• Negative controls using normal IgG are essential to distinguish specific interactions from non-specific binding.
• Co-IP can confirm known interactions, discover novel interaction partners (when combined with mass spectrometry), and study the dynamics of protein complexes.
• Common problems include non-specific binding, weak signal, and protein degradation; these can be addressed by optimizing wash conditions, increasing starting material, and using fresh protease inhibitors.
• Co-IP is complementary to other methods like pull-down assays, yeast two-hybrid, and FRET, each with its own strengths and limitations.

Further Reading

• Lin JS, Lai EM. Protein-Protein Interactions: Co-Immunoprecipitation. Methods in molecular biology (Clifton, N.J.). 2017. PubMed 28667615
• Gnanasekaran P, Pappu HR. Affinity Purification-Mass Spectroscopy (AP-MS) and Co-Immunoprecipitation (Co-IP) Technique to Study Protein-Protein Interactions. Methods in molecular biology (Clifton, N.J.). 2023. PubMed 37450138
• Lin JS, Ali J, Lai EM. Protein-Protein Interactions: Co-immunoprecipitation. Methods in molecular biology (Clifton, N.J.). 2024. PubMed 37930535
• Burckhardt CJ, Minna JD, Danuser G. Co-immunoprecipitation and semi-quantitative immunoblotting for the analysis of protein-protein interactions. STAR protocols. 2021. PubMed 34278331
• Lo Sardo F. Co-Immunoprecipitation (Co-Ip) in Mammalian Cells. Methods in molecular biology (Clifton, N.J.). 2023. PubMed 37212989
• Sciuto MR et al. Two-Step Co-Immunoprecipitation (TIP). Current protocols in molecular biology. 2019. PubMed 30375742

Related Clinical & Scientific Guides

• MAPK Pathway: Mechanism, Function, and Clinical Relevance
• Mammalian Cell Culture Bioreactors: A Practical Guide
• Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks